Resultats de la cerca - Pedro Castelo‐Branco
- Mostrar 1 - 20 resultats de 32
- Anar a la pàgina següent
-
1
Parks in peril: people, politics and protected areas per Silveira, Pedro Castelo Branco
Publicat 2001Online -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis per Ramon Andrade de Mello, Carles Escriu, Pedro Castelo‐Branco, Paloma Cabral, Giannis Mountzios, Gilberto Lopes, Pedro Madureira
Publicat 2017Artigo -
11
-
12
-
13
New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives per Ramon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo‐Branco, Victor André de Almeida Zia
Publicat 2020Revisão -
14
MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway per Ramon Andrade de Mello, Pedro Nazareth Aguiar, Hakaru Tadokoro, Tállita Meciany Farias-Vieira, Pedro Castelo‐Branco, Gilberto Lopes, Daniel Humberto Pozza
Publicat 2018Carta -
15
-
16
Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives per Ramon Andrade de Mello, Rafael Voscaboinik, João Vittor Pires Luciano, Rafaela Vilela Cremonese, Giovanna Araújo Amaral, Pedro Castelo‐Branco, Γεώργιος Αντωνίου
Publicat 2021Revisão -
17
Screening for Colorectal Cancer Leading into a New Decade: The “Roaring ‘20s” for Epigenetic Biomarkers? per Hélder Almeida-Lousada, André Mestre, Sara Ramalhete, Aryeh J. Price, Ramon Andrade de Mello, Ana Marreiros, Ricardo Pires das Neves, Pedro Castelo‐Branco
Publicat 2021Revisão -
18
The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer per Ramon Andrade de Mello, Nathália Moisés Neves, Giovanna Araújo Amaral, Estela Gudin Lippo, Pedro Castelo‐Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Γεώργιος Αντωνίου
Publicat 2020Revisão -
19
Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice? per Ramon Andrade de Mello, Jinhui Zhu, Jairo Iavelberg, Artur Henrique Potim, Débora Simonetti, José Antônio Silva, Pedro Castelo‐Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Maria Tolia, Georgio Antoniou
Publicat 2020Carta -
20
Bifosfonatos: tipos, mecanismos de ação e efeitos colaterais. Revisão da literatura para orientação de profissionais e estudantes das áreas médica e odontológica per Viviann Ruocco Vetucci, Monique Bergantim, Daniel Pedro Castelo Branco Lopes, Diego Nunes Pim, Gustavo Junqueira de Almeida, Rodrigo Nascimento Turano de Mattos, Tiago Varesche Silva, Ana Paula de Souza Faloni
Publicat 2023Artigo
Eines de cerca:
Matèries relacionades
Biology
Medicine
Cancer research
Cancer
Genetics
Gene
Oncology
Internal medicine
Epigenetics
Lung cancer
Biochemistry
Bioinformatics
Disease
Cancer cell
Cell biology
DNA methylation
Gene expression
Immunology
Pathology
Telomere
Carcinogenesis
CpG site
DNA
Methylation
Mutation
Telomerase
Telomerase reverse transcriptase
Adverse effect
Biomarker
Breast cancer